Showing results (2531-2540 of 2,679) with videos related to
Sort By:
Pageof 268
Proceedings of the National Academy of Sciences of the United States of America|December 17, 2008
Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasmaRossa W K Chiu, K C Allen Chan, Yuan Gao, et al.Immunity|March 28, 2026
NF-κB-activated fibroblasts orchestrate inflammaging and emergence of pro-inflammatory granzyme K+ T cellsNancy C Allen, Christian Ringler, Sang Ho Woo, et al.Proceedings of the National Academy of Sciences of the United States of America|February 4, 2015
Lengthening and shortening of plasma DNA in hepatocellular carcinoma patientsPeiyong Jiang, Carol W M Chan, K C Allen Chan, et al.NPJ Genomic Medicine|August 5, 2024
Differential detection of megakaryocytic and erythroid DNA in plasma in hematological disordersW K Jacky Lam, Wanxia Gai, Jinyue Bai, et al.Clinical Chemistry|November 2, 2022
Comparison of Single Molecule, Real-Time Sequencing and Nanopore Sequencing for Analysis of the Size, End-Motif, and Tissue-of-Origin of Long Cell-Free DNA in PlasmaStephanie C Y Yu, Jiaen Deng, Rong Qiao, et al.Journal of the American College of Radiology : JACR|May 6, 2017
ACR Appropriateness Criteria® Prostate Cancer-Pretreatment Detection, Surveillance, and Staging, Fergus V Coakley, Aytekin Oto, et al.Journal of the American College of Radiology : JACR|November 6, 2019
ACR Appropriateness Criteria® Lower Urinary Tract Symptoms-Suspicion of Benign Prostatic Hyperplasia, Lauren F Alexander, Aytekin Oto, et al.European Radiology|March 24, 2019
Distinguishing early-stage nasopharyngeal carcinoma from benign hyperplasia using intravoxel incoherent motion diffusion-weighted MRIQi-Yong Ai, Ann D King, Janet S M Chan, et al.Neuro-Oncology Practice|March 18, 2024
Final report of the phase II NEXT/CNS-GCT-4 trial: GemPOx followed by marrow-ablative chemotherapy for recurrent intracranial germ cell tumorsMargaret Shatara, Megan Blue, Joseph Stanek, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III studyP M Zeltzer, J M Boyett, J L Finlay, et al.Pageof 268